Larvol Delta - Tris-Pharma-Initiates-ALLEVIATE1-and-ALLEVIATE2-Pivotal-Phase-3-Trials-Investigating-Cebranopadol-a-FirstinClass-Compound-with-a-Novel-Mechanism-of-Action-to-Treat-Pain

cebranopadol (TRN-228) - Tris Pharma

https://www.businesswire.com/news/home/20240821421996/en/Tris-Pharma-Initiates-ALLEVIATE-1-and-ALLEVIATE-2-Pivotal-Phase-3-Trials-Investigating-Cebranopadol-a-First-in-Class-Compound-with-a-Novel-Mechanism-of-Action-to-Treat-Pain

Aug 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next